Deep orbital Sub-Q injections to treat enophthalmic sighted eyes in Parry-Romberg syndrome patients.

Deep Orbital Sub-Q Hyaluronic Acid Filler Injection for Enophthalmic Sighted Eyes in Parry-Romberg Syndrome.

Article specifications

This Retrospective, interventional case series study was published in 2018 in Journal of Ophthalmic Plast Reconstr Surg. (IF 2010:1.15) by British and Russian specialists in 2 centers. The aim of the present study was to evaluate deep orbital Sub-Q injections to treat enophthalmic sighted eyes in Parry-Romberg syndrome patients. A total of 8 injections on 3 patients with Parry-Romberg syndrome, and significant enophthalmos is reported. All injections were with deep orbital Sub-Q filler. All patients were females, aged 32, 24, and 52 years old while their symptoms started at 15, 16, and 30 years old, respectively.

 

Results

The result of this study showed that deep orbital Sub-Q hyaluronic injection for treatment of enophthalmos in Parry-Romberg syndrome is an useful option in sighted eyes.